Biotech & Health

Flagship Pioneering’s new venture is betting on tRNA to treat ‘thousands of diseases’

Comment

Transfer RNA (tRNA), molecular model.
Image Credits: LAGUNA DESIGN / Getty Images

On Tuesday, Flagship Pioneering, the major investor behind Moderna, announced yet another addition to their portfolio of RNA-curious companies. Following a year of hype around mRNA, a new company, called Alltrna, will now focus on developing medicines based on Transfer RNA or tRNA.  

At this point, you’re likely familiar with the idea that messenger RNA (mRNA, the stuff used in Moderna and Pfizer’s COVID vaccines), is a set of genetic blueprints that tells the cell to assemble certain amino acids, and join them together into proteins. Think of tRNA as an L-shaped molecule that does the actual work of assembling the amino acids called for in the mRNA blueprint. Transfer RNAs perform one of the final steps our cells use to take genetic code and turn it into a functional protein in the body.

Alltrna’s thesis is that one tRNA could be used to treat “thousands of diseases,” as Lovisa Afzelius, an origination partner at Flagship and co-founding CEO of Alltrna, told TechCrunch. The company has been in proto-mode for the past three years, where its team of 30 people has been developing a “platform” for tRNA therapeutic development. 

“It’s a really critical molecule,” said Afzelius. “Yet it has been, until now, completely overlooked as a modality. What we have developed is a broad tRNA platform that allows us to explore the totality of tRNA biology.” 

Moderna and Pfizer’s COVID-19 vaccines have proved to be a pretty convincing demonstration of what mRNA technology can do. But this has also been a big year for funding for other alternative RNA projects. 

In May, Flagship unveiled Laronde, a company aiming to develop 100 different endless RNA (eRNA) products and drug programs within the next decade (eRNA is a type of RNA developed specifically by Flagship, and is designed to prolong the therapeutic effects of certain medicines, or create “persistent” expression of therapeutic proteins in the body). 

Laronde went on to raise about $440 in Series B funding this year, with investment from Flagship, as well as funds and accounts managed by T. Rowe Price, CPP investments, Fidelity Management and Research Company, Federated Hermes Kaufmann Funds and BlackRock. 

The idea of tRNA-based medicine is still relatively new, but it is starting to attract more attention. Three startups, ReCode Therapeutics, Shape Therapeutics and Tevard Biosciences, have all collectively raised $240 million to develop tRNA-based therapeutics, C&EN reported in September 2021. 

Alltrna’s big sell on tRNA is its potential to intervene in a huge variety of diseases. Theonie Anastassiadis, a principal at Flagship, and co-founder and chief innovation officer of Alltrna, argues tRNAs have the ability to control “many aspects of translation.”

For instance, certain pools of “proliferation tRNAs” are involved in cell division (and some studies have suggested that down-regulating certain tRNAs could be one way to slow cell proliferation in response to cancer). 

TRNAs can also correct issues arising from erroneous genetic code. Some genes may contain mutations that act as premature “stop” signs (called stop codons). These stop signs tell the body to stop making certain proteins, even if the protein isn’t complete, leading to complications. Premature stop codons are a big player in genetic disease, and could be implicated in anywhere from 10% to one-third of all inherited genetic disorders or cancers. 

The idea behind engineering tRNAs, says Afzelius, is that they might read those stop signs anyway, but assemble complete proteins anyway. 

“These actual stop codons can be the same across thousands of diseases. There is the same amino acid that needs to be inserted in all those proteins. We can actually use that same tRNA medicine across that broad range of genetic diseases,” she said. 

Alltrna’s approach to tRNA begins by expanding the tools needed to actually do tRNA-based medicine development. Basic methodologies for expressing tRNAs, measuring their levels, modifying them and synthesizing them are currently “extremely technically challenging” says Anastassiadis. 

“The first thing we did as part of the platform was actually build these tools that are proprietary to Alltrna,” she said. 

The development of this platform for tRNA therapeutics is about as specific as the company will get about its plans. So far, the company has not disclosed any partnerships, nor are they disclosing specific diseases they’re currently working on. 

So far, Flagship has committed $50 million to the Alltrna — the same amount it initially supplied to Laronde this year. In the future, Afzelius says the company will plan to pursue outside investment “when the time is right.” 

 

*This article has been updated to reflect that methodologies developed by Alltrna for studying tRNAs are proprietary.

More TechCrunch

The prospects for troubled banking-as-a-service startup Synapse have gone from bad to worse this week after a United States Trustee filed an emergency motion on Wednesday.  The trustee is asking…

A US Trustee wants troubled fintech Synapse to be liquidated via Chapter 7 bankruptcy, cites ‘gross mismanagement’

U.K.-based Seraphim Space is spinning up its 13th accelerator program, with nine participating companies working on a range of tech from propulsion to in-space manufacturing and space situational awareness. The…

Seraphim’s latest space accelerator welcomes nine companies

OpenAI has reached a deal with Reddit to use the social news site’s data for training AI models. In a blog post on OpenAI’s press relations site, the company said…

OpenAI inks deal to train AI on Reddit data

X users will now be able to discover posts from new Communities that are trending directly from an Explore tab within the section.

X pushes more users to Communities

For Mark Zuckerberg’s 40th birthday, his wife got him a photoshoot. Zuckerberg gives the camera a sly smile as he sits amid a carefully crafted re-creation of his childhood bedroom.…

Mark Zuckerberg’s makeover: Midlife crisis or carefully crafted rebrand?

Strava announced a slew of features, including AI to weed out leaderboard cheats, a new ‘family’ subscription plan, dark mode and more.

Strava taps AI to weed out leaderboard cheats, unveils ‘family’ plan, dark mode and more

We all fall down sometimes. Astronauts are no exception. You need to be in peak physical condition for space travel, but bulky space suits and lower gravity levels can be…

Astronauts fall over. Robotic limbs can help them back up.

Microsoft will launch its custom Cobalt 100 chips to customers as a public preview at its Build conference next week, TechCrunch has learned. In an analyst briefing ahead of Build,…

Microsoft’s custom Cobalt chips will come to Azure next week

What a wild week for transportation news! It was a smorgasbord of news that seemed to touch every sector and theme in transportation.

Tesla keeps cutting jobs and the feds probe Waymo

Sony Music Group has sent letters to more than 700 tech companies and music streaming services to warn them not to use its music to train AI without explicit permission.…

Sony Music warns tech companies over ‘unauthorized’ use of its content to train AI

Winston Chi, Butter’s founder and CEO, told TechCrunch that “most parties, including our investors and us, are making money” from the exit.

GrubMarket buys Butter to give its food distribution tech an AI boost

The investor lawsuit is related to Bolt securing a $30 million personal loan to Ryan Breslow, which was later defaulted on.

Bolt founder Ryan Breslow wants to settle an investor lawsuit by returning $37 million worth of shares

Meta, the parent company of Facebook, launched an enterprise version of the prominent social network in 2015. It always seemed like a stretch for a company built on a consumer…

With the end of Workplace, it’s fair to wonder if Meta was ever serious about the enterprise

X, formerly Twitter, turned TweetDeck into X Pro and pushed it behind a paywall. But there is a new column-based social media tool in town, and it’s from Instagram Threads.…

Meta Threads is testing pinned columns on the web, similar to the old TweetDeck

As part of 2024’s Accessibility Awareness Day, Google is showing off some updates to Android that should be useful to folks with mobility or vision impairments. Project Gameface allows gamers…

Google expands hands-free and eyes-free interfaces on Android

A hacker listed the data allegedly breached from Samco on a known cybercrime forum.

Hacker claims theft of India’s Samco account data

A top European privacy watchdog is investigating following the recent breaches of Dell customers’ personal information, TechCrunch has learned.  Ireland’s Data Protection Commission (DPC) deputy commissioner Graham Doyle confirmed to…

Ireland privacy watchdog confirms Dell data breach investigation

Ampere and Qualcomm aren’t the most obvious of partners. Both, after all, offer Arm-based chips for running data center servers (though Qualcomm’s largest market remains mobile). But as the two…

Ampere teams up with Qualcomm to launch an Arm-based AI server

At Google’s I/O developer conference, the company made its case to developers — and to some extent, consumers — why its bets on AI are ahead of rivals. At the…

Google I/O was an AI evolution, not a revolution

TechCrunch Disrupt has always been the ultimate convergence point for all things startup and tech. In the bustling world of innovation, it serves as the “big top” tent, where entrepreneurs,…

Meet the Magnificent Six: A tour of the stages at Disrupt 2024

There’s apparently a lot of demand for an on-demand handyperson. Khosla Ventures and Pear VC have just tripled down on their investment in Honey Homes, which offers up a dedicated…

Khosla Ventures, Pear VC triple down on Honey Homes, a smart way to hire a handyman

TikTok is testing the ability for users to upload 60-minute videos, the company confirmed to TechCrunch on Thursday. The feature is available to a limited group of users in select…

TikTok tests 60-minute video uploads as it continues to take on YouTube

Flock Safety is a multibillion-dollar startup that’s got eyes everywhere. As of Wednesday, with the company’s new Solar Condor cameras, those eyes are solar-powered and use wireless 5G networks to…

Flock Safety’s solar-powered cameras could make surveillance more widespread

Since he was very young, Bar Mor knew that he would inevitably do something with real estate. His family was involved in all types of real estate projects, from ground-up…

Agora raises $34M Series B to keep building the Carta for real estate

Poshmark, the social commerce site that lets people buy and sell new and used items to each other, launched a paid marketing tool on Thursday, giving sellers the ability to…

Poshmark’s ‘Promoted Closet’ tool lets sellers boost all their listings at once

Google is launching a Gemini add-on for educational institutes through Google Workspace.

Google adds Gemini to its Education suite

More money for the generative AI boom: Y Combinator-backed developer infrastructure startup Recall.ai announced Thursday it has raised a $10 million Series A funding round, bringing its total raised to over…

YC-backed Recall.ai gets $10M Series A to help companies use virtual meeting data

Engineers Adam Keating and Jeremy Andrews were tired of using spreadsheets and screenshots to collab with teammates — so they launched a startup, CoLab, to build a better way. The…

CoLab’s collaborative tools for engineers line up $21M in new funding

Reddit announced on Wednesday that it is reintroducing its awards system after shutting down the program last year. The company said that most of the mechanisms related to awards will…

Reddit reintroduces its awards system

Sigma Computing, a startup building a range of data analytics and business intelligence tools, has raised $200 million in a fresh VC round.

Sigma is building a suite of collaborative data analytics tools